Related Experiment Video
Updated: May 31, 2026

Bile Salt-induced Biofilm Formation in Enteric Pathogens: Techniques for Identification and Quantification
Published on: May 6, 2018
Biofilm formation by Streptococcus pyogenes: modulation of exopolysaccharide by fluoroquinolone derivatives
Raja Mohmed Beema Shafreen1, Shanmugam Srinivasan, Paramasivam Manisankar
1Department of Biotechnology, Alagappa University, Karaikudi-630 003, Tamil Nadu, India.
Abstract:
Biofilm formation by Streptococcus pyogenes has been demonstrated as a potentially important mechanism contributing to antibiotic treatment failure. S. pyogenes is the frequent cause of purulent infections in humans and also, it could play a significant role in recurrent and chronic infections. S. pyogenes biofilm communities tend to exhibit significant tolerance to antimicrobial challenge during infections. The fluoroquinolone derivatives have been previously reported from our laboratory as effective agents against human bacterial pathogens. Therefore, in the present study, we observed the effect of these fluoroquinolones on biofilm formation. Quantitative analysis using 2,3-bis (2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT) at the biofilm inhibitory concentrations (BIC), the compounds 6a, 6c, 7b and 7c reduced 61-71% biofilm and sub-BIC (0.5 and 0.25 BIC) significantly reduced biofilm formation by up to 30-38% and 16-18%, respectively. The Fourier Transform Infrared (FTIR) spectrum of the control and treated S. pyogenes revealed the shift in the chemical entity corresponding to the exopolysaccharide (EPS). The GC/MS analysis showed that the EPS of S. pyogenes has the most abundant neutral sugars l-glucose and d-mannose which is not detected in the fluoroquinolone treated EPS.
Insights
New fluoroquinolone derivatives effectively inhibit Streptococcus pyogenes biofilm formation, a key factor in antibiotic resistance. These compounds target exopolysaccharide production, offering potential for treating persistent bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Streptococcus pyogenes biofilms contribute to antibiotic treatment failure and chronic infections.
- Bacterial biofilms exhibit increased tolerance to antimicrobial agents.
- Fluoroquinolone derivatives have shown efficacy against bacterial pathogens.
Purpose of the Study:
- To investigate the effect of novel fluoroquinolone derivatives on Streptococcus pyogenes biofilm formation.
- To assess the impact of these compounds on bacterial exopolysaccharide (EPS) production.
Main Methods:
- Quantitative biofilm inhibition assays using XTT (2,3-bis (2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide).
- Fourier Transform Infrared (FTIR) spectroscopy to analyze changes in bacterial cell composition.
- Gas Chromatography-Mass Spectrometry (GC/MS) to identify components of the exopolysaccharide matrix.
Main Results:
- Specific fluoroquinolone compounds (6a, 6c, 7b, 7c) significantly reduced S. pyogenes biofilm formation by 61-71% at biofilm inhibitory concentrations (BIC).
- Sub-BIC concentrations (0.5 and 0.25 BIC) also demonstrated significant biofilm reduction (up to 38% and 18%, respectively).
- FTIR and GC/MS analyses indicated that fluoroquinolones alter exopolysaccharide composition, reducing key sugars like l-glucose and d-mannose.
Conclusions:
- Fluoroquinolone derivatives are potent inhibitors of Streptococcus pyogenes biofilm formation.
- These compounds likely exert their effect by disrupting the bacterial exopolysaccharide matrix.
- The findings suggest a promising therapeutic strategy for combating antibiotic-tolerant S. pyogenes infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Inhibitors of Bacterial DNA Synthesis
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Streptococcal Pharyngitis

